EverHint – Momentum Swing Pack – Top 12 Signals for Sep 25, 2026
Excerpt: 12 signals. Healthcare leads (9). price range $8-$94.
Market Context
Equity markets are displaying broad-based strength heading into the session, with all three major indices posting gains and the Dow Jones leading the charge at nearly +1%. The sharp decline in the VIX — now sitting below 15 — signals a meaningful compression in implied volatility and reflects a market environment where participants are actively shedding hedges and embracing risk. This backdrop is constructive for trend-following and breakout strategies, as lower volatility regimes tend to produce cleaner, more sustained directional moves with reduced whipsaw risk.
The subdued VIX reading does create a nuanced dynamic for Volatile High Beta signals specifically. While the overall risk-on tone supports aggressive positioning, compressed volatility can limit the magnitude of intraday swings that high-beta strategies rely on for outsized returns. Traders running these signals should be mindful that although momentum is favorable, the volatility fuel that amplifies high-beta moves is currently running lean. Conversely, Quality Low Volatility and Large Cap signals are well-positioned in this environment, as steady upside with controlled drawdowns aligns precisely with their design parameters.
Healthcare's emergence as the top sector is a notable development worth monitoring for rotation signals. In a low-volatility, risk-on tape, capital often rotates into sectors that offer both growth characteristics and defensive resilience — a profile Healthcare fits well. This rotation suggests institutional positioning may be balancing cyclical exposure with sector-specific opportunity, which reinforces the relevance of the Healthcare-focused signals in today's lineup. The combination of positive index momentum, suppressed fear gauges, and sector leadership creates a generally favorable environment across the majority of the active strategies.
Volatile High Beta
High momentum stock screener for swing trading opportunities. Identifies stocks with strong momentum characteristics suitable for swing trading (1-4 week holds). Includes multiple variants: breakout, pullback, aggressive momentum, and volatile high-beta.
Entry Criteria:
- Strong RSI momentum (configurable thresholds)
- Volume surge above average
- Price momentum confirmation
- Minimum ADV: $25M+ (varies by variant)
- Earnings buffer: 7 days pre/post earnings
- Variant-specific filters applied
Holding period: 1-4 weeks | Risk level: Medium-High
📊 Signals (3 of 3)
Ranked by composite momentum score (higher = stronger momentum)
| # | Ticker | Company | Sector | Price | Score | MCap |
|---|---|---|---|---|---|---|
| 1 | MXL | MaxLinear, Inc. | Technology | $93.84 | 1.00 | $8.5B |
| 2 | CDNA | CareDx, Inc | Healthcare | $63.68 | 0.50 | $3.3B |
| 3 | QMCO | Quantum Corporation | Technology | $31.68 | 0.00 | $1.2B |
Sector Healthcare
High momentum stock screener for swing trading opportunities. Identifies stocks with strong momentum characteristics suitable for swing trading (1-4 week holds). Includes multiple variants: breakout, pullback, aggressive momentum, and volatile high-beta.
Entry Criteria:
- Strong RSI momentum (configurable thresholds)
- Volume surge above average
- Price momentum confirmation
- Minimum ADV: $25M+ (varies by variant)
- Earnings buffer: 7 days pre/post earnings
- Variant-specific filters applied
Holding period: 1-4 weeks | Risk level: Medium-High
📊 Signals (3 of 3)
Ranked by composite momentum score (higher = stronger momentum)
| # | Ticker | Company | Sector | Price | Score | MCap |
|---|---|---|---|---|---|---|
| 1 | NEOG | Neogen Corporation | Healthcare | $13.76 | 1.00 | $3.0B |
| 2 | GMAB | Genmab A/S | Healthcare | $35.32 | 0.50 | $21.7B |
| 3 | PGEN | Precigen, Inc. | Healthcare | $7.75 | 0.00 | $2.8B |
Breakout Standard
Stocks within 3% of 52-week high - standard breakout momentum setups. Stock showing strong momentum near or at highs. Increased volume confirms institutional interest. Breaking out or consolidating near resistance.
Entry Criteria:
- Strong RSI momentum
- Volume surge above average
- Within 3% of 52-week high
- Minimum ADV: $25M+
- Earnings buffer: 7 days
Holding period: 1-4 weeks | Risk level: Medium-High
📊 Signals (4 of 4)
Ranked by composite momentum score
| # | Ticker | Company | Sector | Price | Score | MCap |
|---|---|---|---|---|---|---|
| 1 | NEOG | Neogen Corporation | Healthcare | $13.76 | 1.00 | $3.0B |
| 2 | TBBB | BBB Foods Inc. | Consumer Defensive | $53.56 | 0.47 | $6.2B |
| 3 | GMAB | Genmab A/S | Healthcare | $35.32 | 0.43 | $21.7B |
| 4 | PGEN | Precigen, Inc. | Healthcare | $7.75 | 0.10 | $2.8B |
Quality Low Vol
High momentum stock screener for swing trading opportunities. Identifies stocks with strong momentum characteristics suitable for swing trading (1-4 week holds). Includes multiple variants: breakout, pullback, aggressive momentum, and volatile high-beta.
Entry Criteria:
- Strong RSI momentum (configurable thresholds)
- Volume surge above average
- Price momentum confirmation
- Minimum ADV: $25M+ (varies by variant)
- Earnings buffer: 7 days pre/post earnings
- Variant-specific filters applied
Holding period: 1-4 weeks | Risk level: Medium-High
📊 Signals (1 of 1)
Ranked by composite momentum score (higher = stronger momentum)
| # | Ticker | Company | Sector | Price | Score | MCap |
|---|---|---|---|---|---|---|
| 1 | GMAB | Genmab A/S | Healthcare | $35.32 | 0.00 | $21.7B |
Cap Large Only
High momentum stock screener for swing trading opportunities. Identifies stocks with strong momentum characteristics suitable for swing trading (1-4 week holds). Includes multiple variants: breakout, pullback, aggressive momentum, and volatile high-beta.
Entry Criteria:
- Strong RSI momentum (configurable thresholds)
- Volume surge above average
- Price momentum confirmation
- Minimum ADV: $25M+ (varies by variant)
- Earnings buffer: 7 days pre/post earnings
- Variant-specific filters applied
Holding period: 1-4 weeks | Risk level: Medium-High
📊 Signals (1 of 1)
Ranked by composite momentum score (higher = stronger momentum)
| # | Ticker | Company | Sector | Price | Score | MCap |
|---|---|---|---|---|---|---|
| 1 | GMAB | Genmab A/S | Healthcare | $35.32 | 0.00 | $21.7B |
Field Notes
Sector concentration: Healthcare (9), Technology (2), Consumer Defensive (1)
Data coverage: 0.0% insider (7d), 0.0% congressional (30d), 0.0% earnings, 16.7% news (7d)
Vlad's Take
Today's signals: Strong sector concentration in Healthcare (9 signals) suggests sector-specific rotation.
Independent, data-driven signals.
No hype. No promotions. Just experimental market research from EverHint.
This is not financial advice. Market conditions change rapidly.
Do your own due diligence.
See https://www.everhint.com/disclaimer/ and https://www.everhint.com/faqs/
📢 Support the project by liking, sharing, or subscribing — it helps more readers discover these signals.